Corcept Therapeutics Inc. (NASDAQ:CORT)’s share price rose 1.8% during trading on Monday . The company traded as high as $5.66 and last traded at $5.63, with a volume of 72,288 shares. The stock had previously closed at $5.53.

A number of equities analysts have recently issued reports on CORT shares. Zacks Investment Research raised Corcept Therapeutics from a “hold” rating to a “buy” rating and set a $6.75 price target on the stock in a research report on Tuesday, July 12th. FBR & Co reaffirmed an “outperform” rating and set a $12.00 price target on shares of Corcept Therapeutics in a research report on Thursday, June 23rd.

The stock has a 50-day moving average price of $5.80 and a 200 day moving average price of $4.98. The firm has a market cap of $624.86 million and a price-to-earnings ratio of 627.78.

Corcept Therapeutics (NASDAQ:CORT) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $0.03 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.01 by $0.02. The company had revenue of $19.70 million for the quarter, compared to analysts’ expectations of $18.36 million. On average, analysts anticipate that Corcept Therapeutics Inc. will post $0.05 EPS for the current year.

Corcept Therapeutics Inc is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company’s focus is on those disorders that are associated with a steroid hormone cortisol. Elevated levels and abnormal release patterns of cortisol have been implicated in a range of human disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.